Robert Zegel is a results-oriented pharmaceutical industry executive recognized for implementing innovative strategies and achieving exceptional commercial outcomes. With a solid track record across various roles, they have successfully led cross-functional teams in both global and U.S. markets, overseeing product launches and developing strategic plans. Currently serving as Marketing Director at CSL Behring, Robert manages a portfolio valued at over $2.5 billion and has exceeded revenue targets by executing effective life cycle strategies. Their extensive experience includes leadership positions at Wyeth Pharmaceuticals, Pfizer, and TGaS Advisors, among others, where they consistently drove sales performance and collaborated with diverse stakeholders. Robert earned a Bachelor of Business Administration from the University of Lynchburg.
This person is not in any teams
This person is not in any offices